About MITRO
On September 6-7, 2025, in Shanghai, the Committee of the China Brain Health Initiative (CBHI), in collaboration with CTAD (Clinical Trials on Alzheimer's Disease), will co-host the "China CTAD Advanced Workshop and Course in AD Clinical Trials". This workshop will bring together leading figures among China's top Alzheimer's disease researchers, as well as authoritative experts from Europe and the United States. It aims to build an international collaboration platform, jointly promote the "CTAD China Clinical Trial Center Initiative", explore innovative pathways to systematically enhance clinical trial capabilities, and accelerate the development of new treatment strategies for Alzheimer's disease.
Mitro is honored to participate deeply in this event as a Gold Sponsor and will specially host the symposium "Harnessing PET Biomarkers to Advance Dementia Research" at 8:00 a.m. on September 7. This symposium will feature Professor Piu Chan, Chief Physician of Neurology Department at Xuanwu Hospital, and Dr. Yan Liu, Chief Medical Officer of Mitro. They will share important topics such as building a standardized imaging quality control system in multicenter studies, and the innovative application of cutting-edge scanning technologies and analytical pipelines in drug development. Light refreshments will be provided on site, and we look forward to the presence of expert colleagues for exchange and discussion on cutting-edge advancements!

Previous article
Related News